International audienceHadrontherapy enables a highly localized dose deposition and better organ-at-risk protection, compared to conventional photon radiotherapy. Therefore, the treatment quality strongly relies on the control of the effective ion range in vivo. However, the ballistics makes this technique sensitive to various ion range uncertainties induced by the dose calculation, patient set-up and morphological changes between sessions. In this context, the French CLaRyS collaboration aims to develop various online ion range verification techniques by detecting secondary particles emitted by the patient following nuclear interactions along the ion path. Among them, Prompt-Gamma Imaging consists in the detection of gamma rays by either a ...